Emano Flow is a health care startup that aims to revolutionize the field of urology by providing innovative solutions for remote urinary health monitoring. The company utilizes machine learning to equip patients and practitioners with a comprehensive understanding of urinary health. Patients can conveniently capture audio of their urinations from their smartphones using the company's easy-to-use software. Emano Flow's rigorous machine learning technology accurately predicts flow rate data, and the results are securely shared with providers via a provider portal, enabling real-time monitoring. The company was founded in 2019 by two physicists with a keen interest in healthcare innovation, inspired by their respective fathers, who are a urologist and a nephrologist. Emano Flow recently received a $315.00K Seed Round investment on 27 January 2021. The startup is based in the United States. For more information, visit www.emanoflow.com.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Seed Round | $315.00K | - | 27 Jan 2021 |
No recent news or press coverage available for Emano Flow.